Formalin-fixed paraffin-embedded (FFPE) tissue biopsy material in cancer treatment
The major driver at the moment in genomic research is the incorporation of emerging new technologies and the ability to detect a comprehensive list of genetic biomarkers or variants from very often small amounts of formalin-fixed paraffin-embedded (FFPE) tissue biopsy material, which is then used to match a patient to the ever-increasing list of targeted therapy options for improved outcomes.The All Wales Medical Genomics Service recently announced the launch of a new service that aims to lead the way in the implementation of state-of-the-art genomic testing services into routine clinical practice.
The variants that are detected are the cause of the cancer and therefore the ability of pharma companies to develop drugs that target these genetic variants results in a highly effective treatment for the patient’s cancer with minimal side effects.
Formalin-fixed paraffin-embedded (FFPE) or frozen tissue biopsy material is being analyzed to match a patient to the list of targeted therapy options. As a result, such personalized medicine gives the best value and outcomes for patients.
More info: https://lnkd.in/dEu29cMH
BIOMEDICA CRO is ready to collect high quality human biospecimens to provide scientists with all needed samples for their preclinical studies. Please email us to start our collaboration: office@biomedica-cro.com or visit our page with relevant biospecimens options.
